Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

Treatment for overweight and obesity in adult populations: a systematic review and meta-analysis.

Peirson L, Douketis J, Ciliska D, Fitzpatrick-Lewis D, Ali MU, Raina P.

CMAJ Open. 2014 Oct 1;2(4):E306-17. doi: 10.9778/cmajo.20140012. eCollection 2014 Oct.

PMID:
25485258
[PubMed]
Free PMC Article
2.

Does orlistat cause acute kidney injury?

Beyea MM, Garg AX, Weir MA.

Ther Adv Drug Saf. 2012 Apr;3(2):53-7. doi: 10.1177/2042098611429985. Review.

PMID:
25083225
[PubMed]
Free PMC Article
3.

Obesity: its epidemiology, comorbidities, and management.

Jarolimova J, Tagoni J, Stern TA.

Prim Care Companion CNS Disord. 2013;15(5). pii: PCC.12f01475. doi: 10.4088/PCC.12f01475. Epub 2013 Oct 3. No abstract available.

PMID:
24511434
[PubMed]
Free PMC Article
4.

Long-term drug treatment for obesity: a systematic and clinical review.

Yanovski SZ, Yanovski JA.

JAMA. 2014 Jan 1;311(1):74-86. doi: 10.1001/jama.2013.281361. Review.

PMID:
24231879
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes.

Hollander P, Gupta AK, Plodkowski R, Greenway F, Bays H, Burns C, Klassen P, Fujioka K; COR-Diabetes Study Group.

Diabetes Care. 2013 Dec;36(12):4022-9. doi: 10.2337/dc13-0234. Epub 2013 Oct 21. Erratum in: Diabetes Care. 2014 Feb;37(2):587.

PMID:
24144653
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The role of obesity in cancer survival and recurrence.

Demark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt JA, Ganz PA, Rock CL, Schmitz KH, Wadden T, Philip EJ, Wolfe B, Gapstur SM, Ballard-Barbash R, McTiernan A, Minasian L, Nebeling L, Goodwin PJ.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1244-59. doi: 10.1158/1055-9965.EPI-12-0485. Epub 2012 Jun 13. Review.

PMID:
22695735
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Insulin detemir for the treatment of obese patients with type 2 diabetes.

Hollander PA.

Diabetes Metab Syndr Obes. 2012;5:11-9. doi: 10.2147/DMSO.s266980. Epub 2012 Jan 10.

PMID:
22291472
[PubMed]
Free PMC Article
8.

Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.

Kalil GZ, Haynes WG.

Hypertens Res. 2012 Jan;35(1):4-16. doi: 10.1038/hr.2011.173. Epub 2011 Nov 3. Review.

PMID:
22048570
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Effects of weight loss on serum vitamin D in postmenopausal women.

Mason C, Xiao L, Imayama I, Duggan CR, Bain C, Foster-Schubert KE, Kong A, Campbell KL, Wang CY, Neuhouser ML, Li L, W Jeffery R, Robien K, Alfano CM, Blackburn GL, McTiernan A.

Am J Clin Nutr. 2011 Jul;94(1):95-103. doi: 10.3945/ajcn.111.015552. Epub 2011 May 25.

PMID:
21613554
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Tackling obesity: new therapeutic agents for assisted weight loss.

Karam J, McFarlane S.

Diabetes Metab Syndr Obes. 2010 Apr 26;3:95-112.

PMID:
21437080
[PubMed]
Free PMC Article
11.

Present and future: pharmacologic treatment of obesity.

Glandt M, Raz I.

J Obes. 2011;2011:636181. doi: 10.1155/2011/636181. Epub 2011 Feb 8.

PMID:
21331293
[PubMed]
Free PMC Article
12.

Weight gain, obesity, and psychotropic prescribing.

Nihalani N, Schwartz TL, Siddiqui UA, Megna JL.

J Obes. 2011;2011:893629. doi: 10.1155/2011/893629. Epub 2011 Jan 17.

PMID:
21318056
[PubMed]
Free PMC Article
13.

Impact of orlistat-induced weight loss on diastolic function and heart rate variability in severely obese subjects with diabetes.

Martin J, Paquette C, Marceau S, Hould FS, Lebel S, Simard S, Dumesnil JG, Poirier P.

J Obes. 2011;2011:394658. doi: 10.1155/2011/394658. Epub 2010 Dec 23.

PMID:
21253512
[PubMed]
Free PMC Article
14.

Reversible serum carcinoembryogenic antigen (CEA) elevation due to orlistat use: A case report.

Fernandes Gdos S, Katz A, Calabrich A, Hoff PM.

Clinics (Sao Paulo). 2010 Jun;65(6):645-6. doi: 10.1590/S1807-59322010000600013. No abstract available.

PMID:
20613942
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders.

Heal DJ, Gosden J, Smith SL.

Br J Clin Pharmacol. 2009 Dec;68(6):861-74. doi: 10.1111/j.1365-2125.2009.03549.x.

PMID:
20002080
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Treating diabetes and prediabetes by focusing on obesity management.

Khaodhiar L, Cummings S, Apovian CM.

Curr Diab Rep. 2009 Oct;9(5):348-54. Review.

PMID:
19793504
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis.

Fabricatore AN, Wadden TA, Moore RH, Butryn ML, Gravallese EA, Erondu NE, Heymsfield SB, Nguyen AM.

Obes Rev. 2009 May;10(3):333-41. doi: 10.1111/j.1467-789X.2009.00567.x. Epub 2009 Mar 6. Review.

PMID:
19389060
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Industry funding and the reporting quality of large long-term weight loss trials.

Thomas O, Thabane L, Douketis J, Chu R, Westfall AO, Allison DB.

Int J Obes (Lond). 2008 Oct;32(10):1531-6. doi: 10.1038/ijo.2008.137. Epub 2008 Aug 19. Review.

PMID:
18711388
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Orlistat in the prevention of diabetes in the obese patient.

Mancini MC, Halpern A.

Vasc Health Risk Manag. 2008;4(2):325-36. Review.

PMID:
18561508
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary].

Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E; Obesity Canada Clinical Practice Guidelines Expert Panel.

CMAJ. 2007 Apr 10;176(8):S1-13. Review. No abstract available.

PMID:
17420481
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk